25 Hydroxyvitamin D Serum Concentration and COVID-19 Severity and Outcome-A Retrospective Survey in a Romanian Hospital
- PMID: 36904227
- PMCID: PMC10005256
- DOI: 10.3390/nu15051227
25 Hydroxyvitamin D Serum Concentration and COVID-19 Severity and Outcome-A Retrospective Survey in a Romanian Hospital
Abstract
Interest in the immunomodulatory function of vitamin D has grown since the COVID-19 pandemic started. Our study investigated the possible association between vitamin D deficiency and COVID-19 severity, intensive care needs, and mortality in patients hospitalized with COVID-19. A prospective cohort study was performed on 2342 COVID-19 hospitalized patients between April 2020 and May 2022 in a Romanian tertiary hospital for infectious diseases. A multivariate generalized linear model for binary data was fit with dependent variables: severe/critical form of COVID-19, intensive care need, and fatal outcome as a function of vitamin D deficiency, controlling for age, comorbidities, and vaccination status. More than half of the patients (50.9%) were classified with vitamin D deficiency based on a serum concentration of less than 20 ng/mL. There was a negative association between vitamin D and age. Vitamin D-deficient patients presented with more cardiovascular, neurological, and pulmonary diseases, as well as diabetes, and cancer. In multivariate logistic regression models, vitamin D-deficient patients had higher odds of severe/critical forms of COVID-19 [OR = 1.23 (95% CI 1.03-1.47), p = 0.023] and higher odds of death [OR = 1.49 (95% CI 1.06-2.08), p = 0.02]. Vitamin D deficiency was associated with disease severity and death outcome in hospitalized COVID-19 patients.
Keywords: 25(OH)D deficiency; COVID-19; ICU need; comorbidities; mortality; severity form; vitamin D deficiency.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


References
-
- World Health Organization [(accessed on 22 January 2023)]; Available online: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
-
- World Health Organization [(accessed on 1 February 2023)]; Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on....
-
- World Health Organization [(accessed on 1 February 2023)]; Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2023.1.
-
- UK Health Security Agency COVID-19 Vaccine Surveillance Report. [(accessed on 3 December 2022)]; Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploa....
-
- Thompson M.G., Natarajan K., Irving S.A., Rowley E.A., Griggs E.P., Gaglani M., Klein N.P., Grannis S.J., DeSilva M.B., Stenehjem E., et al. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance—VISION Network, 10 States, August 2021–January 2022. MMWR Morb. Mortal Wkly. Rep. 2022;71:139–145. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous